Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 17/20 | 0.96 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5539944 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL3137867 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL1047418 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL11272759 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL5531525 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL11269252 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL5541351 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL5538850 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL5533203 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 | |
| SCHEMBL5535247 | 0.98 | TBXAS1 (1.00) | TBXAS1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473277-B1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION OR ACID-FUNCTIONALIZED IONIC LIQUID | UNIV DENMARK TECH DTU (DK) | 2019-07-03 | — | — | EP | claimed |
| CN-105148882-B | A kind of metal-organic framework materials are hud typed hydrophilic chromatographic stationary phase of shell and preparation method and application | 河北大学 | 2017-08-25 | — | — | CN | claimed |
| CN-102625731-B | Comprise the palladium catalyst system of the ionic liquid of zwitter-ion and/or acid functionalization | DANMARKS TEKNISKE UNIVERSITET (DK) | 2016-04-06 | — | — | CN | claimed |
| CN-105148882-A | Core-shell type hydrophilic chromatographic stationary phase with metal organic framework material as shell, preparation method and application thereof | UNIV HEBEI | 2015-12-16 | — | — | CN | claimed |
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | AG PLENUS LTD (IL) | 2023-10-19 | — | — | US | disclosed |
| CN-109482230-A | A kind of preparation method of the multicomponent synergistic catalyst for carbon dioxide conversion | 北京工业大学 | 2019-03-19 | — | — | CN | disclosed |
| CN-105148882-B | A kind of metal-organic framework materials are hud typed hydrophilic chromatographic stationary phase of shell and preparation method and application | 河北大学 | 2017-08-25 | — | — | CN | disclosed |
| EP-2943494-B1 | PYRIDO- OR PYRROLO-FUSED PYRIMIDINE DERIVATIVES AS AUTOTAXIN INHIBITORS FOR TREATING PAIN | LILLY CO ELI (US) | 2017-02-22 | — | — | EP | disclosed |
| EP-2943494-B1 | PYRIDO- OR PYRROLO-FUSED PYRIMIDINE DERIVATIVES AS AUTOTAXIN INHIBITORS FOR TREATING PAIN | LILLY CO ELI (US) | 2017-02-22 | — | — | EP | disclosed |
| CN-102625731-B | Comprise the palladium catalyst system of the ionic liquid of zwitter-ion and/or acid functionalization | DANMARKS TEKNISKE UNIVERSITET (DK) | 2016-04-06 | — | — | CN | disclosed |
| CN-105148882-A | Core-shell type hydrophilic chromatographic stationary phase with metal organic framework material as shell, preparation method and application thereof | UNIV HEBEI | 2015-12-16 | — | — | CN | disclosed |
| US-8969555-B2 | Bicyclic pyrimidine compounds | ELI LILLY AND COMPANY (US) | 2015-03-03 | — | — | US | disclosed |
| CN-1105363-A | Quinoline or quinazoline derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-07-19 | — | — | CN | disclosed |
| US-5408036-A | A polyvalent ion covalently linked to 2 to 8 polypeptide binding ligands, each of which covalently bonded to a linear polypeptide | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-04-18 | — | — | US | disclosed |
| EP-0634169-A1 | Pharmaceutical composition containing quinoline or quinazoline derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-18 | — | — | EP | disclosed |
| EP-0608870-A1 | Quinoline or quinazoline derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-08-03 | — | — | EP | disclosed |
| WO-1992006110-A1 | ISOLATED METALLOPOLYPEPTIDE: COMPOSITIONS AND SYNTHETIC METHODS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1992-04-16 | — | — | WO | disclosed |
| US-4795753-A | Certain pyridyl or imidazol-1-yl-alkyleneoxy-(or amino)phenoxy-alkanoates having lipid lowering activity | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1989-01-03 | — | — | US | disclosed |
| US-4355170-A | ANTIINFLAMMATORY, HYPERTENSIVE, ANTIASTHMATIC AGENTS, A THROMBOXANE SYNTHETASE INHIBITORS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1982-10-19 | — | — | US | disclosed |
| US-4256757-A | ANTIINFLAMMATORY AND HYPOTENSIVE AGENTS; THROMBOSIS; ASTHMA; NERVOUS SYSTEM DISORDERS | ONO PHARMACEUTICAL CO., LTD. | 1981-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | DDT, HDHD5, HPD | TBXAS1 4592/4885EGLN3 163/4885ALDH1A1 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.